323 Acknowledgements CURRICULUM VITAE Mehmet Nizamoglu was born on 29 June 1992 in Kadikoy, Istanbul. He obtained his bachelor’s degree in Molecular Biology and Genetics with high honors from Middle East Technical University (METU) in Ankara, Turkey, in 2016. In 2017, he was granted a full scholarship to participate in the Erasmus Mundus Joint Master’s Degree program, International Master’s in Innovative Medicine (IMIM). He pursued his studies at Uppsala University in Sweden, specializing in Medical Research for his Master’s Degree. His Master’s thesis research focused on developing alternative crosslinking strategies for methacrylated gelatin hydrogels at the Department of Polymer Chemistry in Chemistry-Angstrom. Subsequently, he joined the University of Groningen in the Netherlands for the Medical and Pharmaceutical Drug Innovation (MPDI) Master’s program, where he conducted research at the Department of Pathology and Medical Biology in the University Medical Center Groningen (UMCG). His research at UMCG aimed to develop alternative methods for generating hydrogels from native tissue by exploring alternatives to pepsin digestion. In the summer of 2019, he finalized his double degree with a cum laude distinction in his Master’s in Medical and Pharmaceutical Drug Innovation. In September 2019, Mehmet embarked on a 2+2 Industrial PhD project with the Experimental Pulmonology and Inflammation Research (EXPIRE) group, a collaborative project between UMCG and Boehringer Ingelheim. Throughout his PhD trajectory, he presented his research at national and international scientific congresses. In addition to his scientific contributions, he actively participated in various roles within the academic community. He served as a member of the organizing committee for the Industry Perspectives in Medicine (IPIM) Summer School and successfully organized two editions of the summer school in 2020 and 2021. In 2021, he became involved with the PhD council of the Groningen University Institute of Drug Exploration (GUIDE) and assumed the role of chair in 2022. Mehmet also joined the Early Stage Researchers’ committee of the Dutch Society for Matrix Biology (NVMB) in 2022, eventually becoming a board member as the representative for early stage researchers. After concluding his PhD, he transitioned to a new career as a project manager at UMCG Research BV within the UMCG in Groningen, the Netherlands.
RkJQdWJsaXNoZXIy MTk4NDMw